Journal: bioRxiv
Article Title: Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a mechanism involving membrane-bound TGF-β1
doi: 10.1101/2025.02.21.639264
Figure Lengend Snippet: (A) CellTrace Violet (CTV) dilution of unstimulated and CD3/CD28 stimulated T cells after 5-day co-culture with monocytes or HuMoSC at the indicated ratios (T cell:HuMoSC). (B) Tumorsphere formation assay of MCF7 cells alone or in co-culture with Human Monocyte-derived Suppressive Cells (HuMoSC) at the indicated ratio or monocytes at a 1:5 (MCF7:monocyte) ratio. (C) Live videomicroscopy representative images of ZsGreen-expressing MCF7 cells (green) alone or in co-culture with CellTrace Far Red-stained HuMoSC or monocytes (red) in tumorsphere forming conditions (MCF7:HuMoSC or monocyte ratio of 1:5). (D) Tumorsphere formation live videomicroscopy quantification of ZsGreen intensity over time of MCF7 cells alone (green) or in co-culture with HuMoSC (red) or monocyte (grey) (MCF7:HuMoSC or monocyte ratio of 1:5). Dashed line: 16h timepoint. (E-K) All analyses were performed on FACS-sorted MCF7 pre-cultured alone or with HuMoSC for 72 hours in adherent, classical 2D culture conditions (MCF7:HuMoSC or monocyte ratio of 1:5). (E) Normalized tumorsphere-forming efficiency of MCF7 cells pre-cultured alone or with HuMoSC or monocytes prior to seeding in tumorsphere forming conditions. (F) In vitro Extreme Limiting Dilution Assay (ELDA) of the tumorsphere formation ability of MCF7 cells. The number of wells presenting tumorspheres and total number of wells assayed in each condition is indicated (n). TFF, Tumorsphere Forming Frequency. (G and H) Representative FACS plots (left) and normalized proportion (right) of CD44 + CD24 - MCF7 cells (G) and ALDH + MCF7 cells (H). (I) GSEA plot showing the Normalized Enrichment Score (NES) and associated p-value for the EMT Hallmark gene set in the variance-ranked genes for MCF7 cells cultured 24h with HuMoSC compared to MCF7 cells cultured alone. FDR: False Discovery Rate. (J) Bubble plot showing the upregulation of EMT-related Kegg signaling pathways in MCF7 cultured for 24 hours with HuMoSC compared to MCF7 cultured alone. Pathways of interest are highlighted in red. (K) Monocyte-to-HuMoSC immunosuppression potential upon T-cell coculture (left, red) and MCF7 tumorsphere formation assay after co-culture with HuMoSC (right, blue) at each day of their polarization from monocytes (Day 0) to HuMoSC (Day 7). (L) CellTrace Violet dilution of T cells unstimulated (Unstim), stimulated with anti-CD3/CD28 (Stim) or stimulated and co-cultured with CD33 low or CD33 high myeloid cells isolated from pleural effusion of breast cancer patients. (M) Tumorsphere formation assay of MCF7 cells alone or in co-culture with CD33 low or CD33 high isolated from pleural effusion of breast cancer patients. Data are means ± S.E.M. ∗p < 0.05, ∗∗p < 0.01, $$$/∗∗∗p < 0.001, $$$$/∗∗∗∗p < 0.0001. ns, not significant. Kruskal-Wallis test with Dunn’s multiple comparisons post-test (B, D, E, K, M); Tumorsphere Forming Frequency (TFF) and associated p-value was calculated using ELDA software (F); Student’s unpaired t-test (G, H).
Article Snippet: MCF7 human Luminal A breast cancer cell line was purchased from the ATCC.
Techniques: Co-Culture Assay, Tube Formation Assay, Derivative Assay, Expressing, Staining, Cell Culture, In Vitro, Limiting Dilution Assay, Protein-Protein interactions, Isolation, Software